Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 521 - Heterocyclic compounds containing unspecified hetero rings
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
09/2003
09/03/2003CN1440396A Colchinol derivatives as angiogenesis inhibitors
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1120167C Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles having an affinity for alpha and/or 5HTIA receptors
09/03/2003CN1120154C 4-hydroxy-piperdine derivatives
09/02/2003US6613944 Process to produce 3-carbon amino alcohol salts
09/02/2003US6613911 Reaction of haloarylacetic acids or esters with olefins to give vinylarylacetic acids or esters, oxidation with an oxidizing reagent gives formylarylacetic acids or esters
09/02/2003US6613776 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease
09/02/2003US6613772 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
09/02/2003US6613761 (3R,5S)-N- methanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl) -1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4, 1-benzoxazepine-3-acetamide, used as antilipemic agents and enzyme inhibitors
09/02/2003CA2216796C Quinazoline derivatives
08/2003
08/28/2003WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003WO2003070247A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/28/2003US20030162823 Novel C-4 substituted retinoids
08/28/2003US20030162794 Benzazole derivatives and their use as jnk modulators
08/28/2003US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
08/28/2003US20030162690 Bood anticoagulant
08/28/2003US20030162661 Selective control of harmful plants in crops of useful plants
08/28/2003CA2476936A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337524A1 Substituted quinolines as antitumor agents
08/27/2003EP1337523A2 2,4-substituted pyridine derivatives
08/27/2003EP1337516A1 Process for manufacture of imidazoles
08/27/2003EP1337513A1 4-substituted quinolines as antitumor agents
08/27/2003CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438997A Inhibitors of 11-beta-hydroxy steroid dehydrogenase typeÔàá"
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1438883A Beta Secretase inhibitors
08/27/2003CN1119344C Heterocyclic substed, pyrrolidine amide derivatives
08/26/2003US6610737 Non-psychotropic cannabinoids
08/26/2003US6610723 Imidazole derivatives
08/26/2003US6610701 For therapy and prophylaxis of blood coagulation and cardiovascular disorders
08/26/2003US6610677 Enhancing glycogen synthesis, lowering blood levels of glucose, treating colon, ovarian, or breast cancer, treating diabetes, treating schizophrenia
08/26/2003US6610641 Transition metal complex
08/21/2003WO2003068770A1 R- (-) -1- [2- (7-CHLOROBENZO [b] THIOPHEN-3 -YL- METHOXY) -2- (2,4-DICHLOROPHENYL) -ETHYL] -1H-IMIDAZOLE
08/21/2003WO2003068758A1 Optically active azole derivative and process for producing the same
08/21/2003WO2003068738A1 Pyrrole derivatives as ligands of melanocortin receptors
08/21/2003WO2003068725A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
08/21/2003US20030158238 Treating diseases such as cancer, inflammatory disorders, restenosis,
08/21/2003US20030158210 Amino acid ester containing azole antifungals
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158198 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
08/21/2003US20030158186 Compositions and methods for treating heart failure
08/21/2003US20030158177 Treating or preventing obesity
08/20/2003EP0776330B1 Photolabile compounds and methods for their use
08/20/2003CN1437603A Oxazolidinone derivatives with antibiotic activity
08/20/2003CN1437588A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type l
08/20/2003CN1437578A (P-amino-hyaroxyphenyl)-acrylamide derivatives and dyes containing said compounds
08/19/2003US6608093 Polyarylpyrazole or polyarylpyrole or polyaryltriazole compounds or intermediates for pesticides
08/19/2003US6608058 6-methylnicotinamide derivatives as antiviral agents
08/14/2003US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders
08/14/2003US20030153604 Anticoagulants
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153463 Substituted aryl sulphonyl(thio)ureas
08/13/2003EP1334099A4 Herbicidally active pyridine sulfonyl urea derivatives
08/13/2003EP1334099A1 Herbicidally active pyridine sulfonyl urea derivatives
08/13/2003EP1334094A1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003EP1333831A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
08/13/2003EP1333795A1 Novel coupler for use in oxidative hair dyeing
08/13/2003EP0901477B1 Sulphonyl-mercapto-triazolyl derivatives and their use as microbicides
08/13/2003EP0837859B1 Tetrahydrofuran antifungals
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1117745C Noval tricyclic N-cyanoimines useful as inhibitors of farnesyl-protein transferase
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605629 Oxazole derivatives; low toxicity
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/07/2003WO2003064411A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149063 For therapy of ras- oncogene-dependent tumors, such as cancers of pancreas, colon, bladder, and thyroid; useful for controlling metastasis, suppressing angiogenesis, inducing apoptosis, and Ras-associated proliferative diseases
08/07/2003US20030149048 For therapy of hyperproliferative disorder in a mammal
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030149041 For prophylaxis and therapy of inflammation, asthma, arthritis, diabetes, atherosclerosis, ocular diseases, restenosis, autoimmune responses, multiple sclerosis, psoriasis, human cancers, fibrosis of liver, lung and kidney
08/07/2003US20030149035 For therapy and prophylaxis of infections by herpesviruses
08/07/2003US20030145641 Fertilization mixture containing pyrazole compound
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/06/2003EP1333029A1 Pyrimidine derivatives and herbicides containing the same
08/06/2003EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP0912093B1 (hetero)aryl sulphonyl ureas with an iminofunction, the preparation and use thereof as herbicides and plant growth regulators
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003CN1434821A Quinazoline derivatives for the treatment of tumours
08/06/2003CN1434812A Thizaolyl amide derivatives
08/06/2003CN1434794A Adamantane derivatives
08/06/2003CN1117071C Pesticides
08/05/2003US6602877 Imidazolyl-cyclic acetals
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602863 Irreversible inhibitors of tyrosine kinases
08/05/2003CA2264511C Compounds useful for inhibition of farnesyl protein transferase
07/2003
07/31/2003WO2003062388A2 Inhibition of rna function
07/31/2003WO2002020500A3 Materials and methods to potentiate cancer treatment
07/31/2003US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4
07/31/2003US20030144286 Nitrogen compounds such as 3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide, used as nonsteroidal antiinflammatory agents, immunology or interleukin receptor associated kinase (IRAK) modulators; rheumatic diseases; multiple sclerosis
07/31/2003US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis
07/31/2003US20030144263 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
07/30/2003EP1144406B1 Antifungal azole derivatives having a fluorinated vinyl group and process for preparing same
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 163